Background
==========

Data from epidemiological studies have shown that gender has an important impact on the incidence of active infective endocarditis (AIE) of the aortic valve, with a greater proportion of men being affected. To date, the literature has shown this incidence as male-to-female ratios, which range from 2:1 to 9:1 \[[@b1-medscimonit-22-2520],[@b2-medscimonit-22-2520]\]. A healthy native valve is normally protected against bacteria by an intact endothelium; however, in patients with endocarditis, this endothelium is no longer a confluent monolayer and bacteria can attach to the surface to form a biofilm \[[@b3-medscimonit-22-2520]\]. This bacterial biofilm is a complex system, with inherent resistance to antimicrobial agents owing to encapsulation. This encapsulation includes bacteria arranged in organized structures that produce extracellular polymeric substances, and proteolytic enzymes that destroy the surrounding tissue and increase the infection \[[@b4-medscimonit-22-2520]\]. Data from previous animal studies have suggested that oestrogen is a protector against endothelial cell damage \[[@b5-medscimonit-22-2520]\], which could explain the difference in incidence of endocarditis between men and women. Song et al. demonstrated the antioxidant effect of oestrogen on bovine aortic endothelial cells \[[@b6-medscimonit-22-2520]\]. Other studies have also demonstrated that estrogen deficiency and microphageal migration were more pronounced because of a reduction in junction proteins between endothelial cells \[[@b7-medscimonit-22-2520]\].

In the literature, if AIE is present and surgical treatment is required, female gender seems to no longer be an independent protective factor, but becomes an independent predictor for significantly increased risk of early mortality \[[@b8-medscimonit-22-2520]--[@b10-medscimonit-22-2520]\]. Women also have a higher co-morbidity (e.g., from renal failure and diabetes), which could also influence the prognosis after AIE surgical treatment \[[@b11-medscimonit-22-2520],[@b12-medscimonit-22-2520]\]. However, long-term follow-up in other studies did not indicate a greater risk for morbidity and mortality in women \[[@b13-medscimonit-22-2520]--[@b15-medscimonit-22-2520]\]. Many aspects of the influence of gender on AIE are still not completely understood, especially as partially contradicting data have been published. The aim of this observational, single-center study was to evaluate the impact of gender on early and late surgical outcome in patients with AIE and define independent risk factors for male and female patients.

Material and Methods
====================

Definitions and patients
------------------------

This single-center study involved adult patients (aged ≥18 years) who had undergone surgery for AIE at the Leipzig Heart Center, Germany. Patients with AIE were included according to the modified Duke criteria \[[@b16-medscimonit-22-2520]\]. Data were collected prior to surgery and as the study was ongoing. Definitions for active, prosthetic, and culture-negative endocarditis were followed as published by Renzulli et al. \[[@b17-medscimonit-22-2520]\]. Details have been previously described \[[@b8-medscimonit-22-2520]\].

Patient variables were analysed based on previous studies \[[@b8-medscimonit-22-2520]\] and their correlation with operative mortality \[[@b8-medscimonit-22-2520]\].

Early mortality was defined as 30-day mortality. Postoperative complications were defined as complications occurring within the hospital stay. Late mortality included all deaths that occurred during follow-up after 30 days, up to an average duration of 3.5±3.8 years (range 0.1--16.9 years).

Surgical techniques
-------------------

Surgical techniques included complete median sternotomy and partial upper sternotomy. If concomitant bypass surgery was performed in patients younger than 70 years of age, complete arterial revascularisation was performed. However, for the left descending artery, the internal thoracic artery was always used. In other cases, a saphenous vein was also used. After aortic cross-clamping, patients received either cold blood cardioplegia or crystalloid solution.

In all cases, excessive excision of all infected or necrotic tissue, while leaving a generous margin of healthy tissue, was performed. Aortic valve replacement (including tissue reconstruction, if needed) was then induced with or without concomitant procedures. All patients received intravenous antibiotic therapy for at least 6 weeks postoperatively according to the European Society of Cardiology guidelines for the treatment of endocarditis \[[@b18-medscimonit-22-2520]\].

Follow-up
---------

Follow-up was undertaken annually over 12 years and performed by using the entered patient data into the institutional database for quality control purposes. Written informed consent was obtained from all patients, but since all data entered were de-identified and this was a retrospective study, individual patient informed consent was waived by our institutional ethics committee. Information for follow-up after discharge was gained from a direct telephone interview or the referring physician. If complications were communicated from a direct telephone interview, these data were confirmed by contacting the referring physician, obtaining copies of patient medical records, or analysing post-mortem examinations (if available). These data could also be confirmed at the Ambulatory Department via an echocardiographic follow-up.

Statistical analysis
--------------------

Data were entered into Microsoft^®^ Excel worksheets (Microsoft Corp., Redmond, WA) and transferred to SPSS (version 17.0; SPSS, Inc., Chicago, IL) for statistical analysis. The follow-up time for survival was measured from the date of the operation to either the date of death or the date the patient was last contacted while still alive.

Quantitative data were characterized by mean and standard error of the mean, whereas qualitative data were characterized by relative frequencies and percentages. Male and female patients were compared using Student's t-test for continuous variables, and chi-square and Fischer's exact test for categorical variables. Long-term survival was analysed by the Kaplan-Meier method, and different groups were compared by log-rank tests. Research on characteristics associated with 30-day and total mortality was performed by logistic and Cox regression analyses, respectively. Common potential risk factors and covariates were tested in univariate analyses separately for women and men. Characteristics significant at 10% level (separated by sex) were assessed by forward stepwise Cox regression analysis. Final models, which were established by variables included in the stepwise procedure, were fitted to estimate hazard ratios (HRs) and 95% confidence interval (CI) limits. These results were depicted by forest plots, applying the R package Hmisc \[[@b19-medscimonit-22-2520]\]. All statistical tests were performed as 2-sided tests at a 5% significance level.

Results
=======

Patients
--------

A total of 1394 patients (978 men, 416 women) with AIE were included between October 1994 and January 2011. A subgroup of 755 patients (558 male \[73.9%\] and 197 female \[26.1%\]) with AIE of the aortic valve were identified and included in the study analysis.

Patient characteristics are presented in [Table 1](#t1-medscimonit-22-2520){ref-type="table"}. There was a highly significant difference between men and women. Furthermore, comorbidities were significantly different in both groups, with a higher incidence of ischaemic cardiomyopathy in male patients versus female patients. However, compared with male patients, female patients had a significantly higher occurrence of diabetes, and a significantly higher occurrence of preoperative stroke and higher age.

Operative results
-----------------

There were 743 patients (98.4%) who had a complete median sternotomy, including 551 male (98.7%) and 192 female patients (97.5%). Eleven patients had a partial upper sternotomy (7 male \[1.3%\] and 4 female patients \[2.0%\]). One female patient (0.5%) was converted to full sternotomy. There were 215 patients (28.5%) who received cold blood cardioplegia (155 male, 60 female) and 538 patients who received crystalloid solution (401 male, 137 female). Two patients underwent surgery on a fibrillating heart.

Surgical data are provided in [Table 2](#t2-medscimonit-22-2520){ref-type="table"}. The choice of implanted prosthesis was similar in both groups; however, involvement of the mitral valve (MV) was more common in female patients than in male patients. Other concomitant procedures, such as tricuspid valve surgery, were also significantly more common in women compared with men. Nevertheless, there was no significant difference among men and women in the cross-clamp time (89.5±48.1 min *vs.* 87.8±46.6 min, respectively \[p=0.644\]) or extracorporeal circulation time (135.1±81.6 min *vs.* 133.1±72.7 min, respectively \[p=0.743\]).

Postoperative morbidity
-----------------------

Postoperative complications are presented in [Table 3](#t3-medscimonit-22-2520){ref-type="table"}. In both groups, neurological complications by preoperative embolism because of AIE were similar, and were observed as transient ischaemic attack or somnolency. Postoperative renal dialysis was significantly more common in women than in men (50/197 \[25.4%\] *vs.* 103/558 \[18.5%\], respectively; p=0.038). Preoperative chronic renal failure was 25.4% in the overall group, showing no differences between genders. Similar data were found on the preoperative chronic renal failure with dialysis: 14/198 (7.1%) in female patients and 31/558 (5.6%) in male patients.

Early mortality
---------------

The overall 30-day mortality rate was 17.2%, with 15.0% of men *vs.* 23.5% of women affected (p=0.01). All causes of death, including early mortality, are shown in [Table 4](#t4-medscimonit-22-2520){ref-type="table"}. Univariate analysis showed risk factors associated with 30-day mortality for both genders, which included elderly age, high LVEF (prior operation, previous cardiac surgery, previous dialysis, ventilation prior to OP, low cardiac output, and high New York Heart Association (NYHA) class.

In male patients, 30-day mortality was significantly associated with age (HR 1.42, 95% CI 1.14--1.78; p=0.002), insulin-dependent diabetes (HR 2.25, 95% CI 1.39--3.65; p=0.001), prior cardiac surgery (OR 2.29, 95% CI 1.44--3.65; p\<0.001), preoperative preserved EF (HR 0.98, 95% CI 0.97--1.00; p=0.024), NYHA Class IV (HR 2.28, 95% CI 1.40--3.71; p=0.001), and kissing MV endocarditis (HR 2.37, 95% CI 1.44--3.91; p=0.001) at multiple regression analysis. In female patients, the multiple regression analyses detected an association between 30-day mortality and age (HR 1.52, 95% CI 1.23--1.87; p\<0.001), preoperative dialysis (HR 3.57, 95% CI 1.70--7.51; p=0.001), and endocarditis focus identification (HR 3.03, 95% CI 1.18--7.78; p=0.022).

Long-term results
-----------------

The Kaplan-Meier curve revealed that, compared with women, men who underwent surgery for AIE of the aortic valve had a statistically significant longer overall survival (p=0.002; [Figure 1](#f1-medscimonit-22-2520){ref-type="fig"}). However, there was no significant difference after 10 years.

For men and women, factors associated with overall survival included: increased age (men: HR 1.63, 95% CI 1.43--1.86; p\<0.001 *vs.* women: HR 1.53, 95% CI 1.28--1.82, p\<0.001); preoperative dialysis (men: HR 1.89, 95% CI 1.20--2.98; p=0.006 *vs.* women: HR 3.65, 95% CI 1.96--6.77, p\<0.001); and double-valve involvement (men: HR 1.65, 95% CI 1.24--2.19 p=0.001 *vs.* women: HR 1.52, 95% CI 1.02--2.26, p=0.040).

The following independent risk factors were significant for male patients only: preoperative preserved EF (HR 0.99, 95% CI 0.98--0.99, p=0.002), insulin-dependent diabetes (HR 2.02, 95% CI 1.48--2.75, p\<0.001), previous cardiac surgery (HR 1.62, 95% CI 1.22--2.13, p=0.001), preoperative ventilation (HR 1.77, 95% CI 1.14--2.75, p=0.012), and NYHA Class IV (HR 1.56, 95% CI 1.12--2.15, p=0.008). In contrast, endocarditis focus identification (HR 1.73, 95% CI 1.08--2.77, p=0.023) was an additional significant risk factor for female patients only. Multivariate analyses of variables influencing late mortality of women are shown in [Figure 2](#f2-medscimonit-22-2520){ref-type="fig"}. Variables independently associated with late mortality of men are shown in [Figure 3](#f3-medscimonit-22-2520){ref-type="fig"}. For both subgroups, age and dialysis were independent risk factors for late death.

Discussion
==========

Gender itself seems to have a major role in the incidence of valvular heart disease. This study demonstrated distinct gender-based differences in patients with AIE who were undergoing surgical treatment. Women seem to have higher mortality rates because of factors such as underdiagnosed pulmonary disease, higher rates of postoperative pulmonary infection, and consecutively longer ventilation and ICU stays \[[@b20-medscimonit-22-2520],[@b21-medscimonit-22-2520]\]. This is not the explanation we found in this study for the increased early and late mortality in female patients. The strength of this study was the accuracy of data collection and disease diagnosis owing to the direct visual intraoperative valve analysis performed by the surgeon with respect to specific valve characteristics.

Patient characteristics
-----------------------

In this cohort, women with AIE who underwent surgery were on average 4 years older than the men. Thus, women undergoing surgery due to AIE would have no longer been protected by estrogen. The cardiovascular risk factor of diabetes was much more prominent among women with AIE undergoing surgery (36.5%) than men (28.5%). The severity of diabetes and risk of cardiovascular events seem to have a different role in women than in men \[[@b22-medscimonit-22-2520]\].

Similar to what has been previously described in the literature \[[@b23-medscimonit-22-2520]\], the incidence of stroke in this cohort was higher among women. This could be because steroid hormones only protect against cerebrovascular events premenopausal compared with men at the same age \[[@b24-medscimonit-22-2520],[@b25-medscimonit-22-2520]\], but after menopause the incidence of stroke rapidly increases \[[@b26-medscimonit-22-2520]\]. Additionally, the female patient population in this cohort had an increased number of patient with diabetes, which is also associated with an increased risk for stroke \[[@b27-medscimonit-22-2520]\].

Operative results
-----------------

MV involvement in AIE seems to be more prominent among women and may lead to a higher incidence of MV replacement in this gender. This higher rate could be attributable to more severe calcification based on gender-specific differences in calcium metabolism and bone resorption, especially among postmenopausal women. However, further trials are required to establish this factor \[[@b10-medscimonit-22-2520]--[@b12-medscimonit-22-2520]\].

Sambola and colleagues examined 271 patients with endocarditis \[[@b15-medscimonit-22-2520]\]. These results showed increasing age and a higher incidence of MV disease were risk factors for women with AIE. These results are supported by Pfannmüller et al. \[[@b28-medscimonit-22-2520],[@b29-medscimonit-22-2520]\]. Unlike the Sambola study, women did not refuse surgical procedures during our investigation. Gammie and colleagues investigated more than 400 000 patients and identified female gender as having no significant effect on patient outcome after MV surgery alone (OR 1.4) \[[@b30-medscimonit-22-2520]\]. Tricuspid valve disease seems to be underdiagnosed in women, leading to higher mortality rates in the general population. Concomitant aortic surgery was more frequently observed in male patients \[[@b30-medscimonit-22-2520]\].

Postoperative morbidities
-------------------------

The incidence of heart failure, independent of the underlying pathology, increases considerably in women aged 55 years and older \[[@b31-medscimonit-22-2520]\]. This factor also seems to account for the stronger correlation between age and mortality observed in women with cardiovascular disease. Regitz-Zagrosek described the higher NYHA functional class as the strongest predictor for the development of heart failure and mortality in men, but the strongest predictor for women is age \[[@b31-medscimonit-22-2520]\].

Early mortality
---------------

To the best of our knowledge, no study has been conducted to compare male and female patients with risk factors for early mortality; however, a previous study showed gender to be an independent risk factor for in-hospital mortality (OR 7.56; 95% CI 1.31--43.69, p=0.0147) \[[@b8-medscimonit-22-2520]\]. This study also showed that renal failure had a tremendous influence on in-hospital mortality (OR 5.94; 95% CI 0.95--37.24, p=0.0524). Musci et al. was only able to show in univariate analyses that diabetes mellitus had a moderately elevated OR of 2.17 \[[@b1-medscimonit-22-2520]\]; which was confirmed by the multivariate analyses of our study for male patients.

Long-term results
-----------------

Based on the pathology of disease, more women received a prosthetic MV replacement compared with men. More investigations with regard to the gender-dependent differences in the demographical data of patients with AIE who are undergoing surgery are awaited.

Conclusions
===========

This study demonstrated distinct gender-based differences in risk of mortality in patients with AIE who were undergoing surgical treatment. The data also indicate differences in disease patterns, comorbidities, intraoperative surgical treatment strategy, and long-term outcome.
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###### 

Baseline patient characteristics specified by gender.

                                           Overall (n=755)   Women (n=197)   Men (n=558)   P Value
  ---------------------------------------- ----------------- --------------- ------------- -----------
  Age (years)                              62.5±13.9         64.9±14.1       61.6±13.7     0.005
  Native valve endocarditis                545 (72.2%)       144 (73.1%)     401 (71.9%)   0.740
  Prosthetic valve endocarditis            210 (27.8%)       53 (26.9%)      157 (28.1%)   0.740
  Mitral valve involvement                 178 (23.6%)       54 (27.4%)      124 (22.2%)   0.140
  Co-morbidity                                                                             
   Heart failure (III+IV)                  434 (57.5%)       116 (58.9%)     318 (57.0%)   0.644
   NYHA III                                342 (39.0%)       86 (41.3%)      256 (38.3%)   
   NYHA IV                                 162 (18.5%)       34 (16.3%)      128 (19.1%)   
   Peripheral vessel disease               81 (10.7%)        17 (8.6%)       64 (11.5%)    0.268
   DM                                      231 (30.6%)       72 (36.5%)      159 (28.5%)   **0.035**
   Stroke                                  200 (26.5%)       64 (32.5%)      136 (24.4%)   **0.026**
   COPD                                    83 (11.0%)        15 (7.6%)       68 (12.2%)    0.078
   Preoperative ventilation                64 (8.5%)         19 (9.6%)       45 (8.1%)     0.494
   Chron. renal failure                    147 (19.5%)       113 (28.8%)     113 (20.3%)   0.727
   Dialysis                                45 (6.0%)         14 (7.1%)       31 (5.6%)     
   Neoplastic disease                      (19.2%)           (19.2%)         (19.1%)       
  Echocardiographic findings (LV EF)                                                       
   \>50%                                   473 (62.6%)       125 (63.5%)     348 (62.4%)   0.071
   30--50%                                 224 (29.7%)       65 (32.5%)      160 (28.7%)   
   ≤30%                                    58 (7.7%)         9 (4.3%)        50 (9.0%)     
  Presence of aortic vegetation                                                            
  Size (\>10mm)                            430 (57.0%)       112 (56.9%)     318 (57.0%)   0.973
  Aortic abscess                           87 (11.5%)        23 (11.7%)      64 (11.5%)    0.938
  Presence of aortic valve regurgitation   641 (84.9%)       159 (80.7%)     482 (86.4%)   0.056
  Number of valves involved                                                                
   1                                       562 (74.4%)       137 (69.5%)     425 (76.2%)   0.067
   2 or more                               193 (25.6%)       60 (30.5%)      133 (23.8%)   
  Complications                                                                            
   Septic Emboli                           334 (44.2%)       88 (44.7%)      246 (44.1%)   0.887
   Localisation                                                                            
    Brain                                  172 (22.8%)       43 (21.8%)      129 (23.1%)   0.710
    Lung                                   17 (2.3%)         3 (1.5%)        14 (2.5%)     0.423
    Spleen                                 209 (27.7%)       45 (22.8%)      164 (29.4%)   0.077
    Kidney                                 80 (10.6%)        19 (9.6%)       61 (10.9%)    0.614
    Limb                                   43 (5.7%)         11 (5.6%)       32 (5.7%)     0.937
    Other                                  30 (4.0%)         9 (4.6%)        21 (3.8%)     0.619
    Mech. Support preoperative IABP        22 (2.9%)         7 (3.6%)        15 (2.7%)     0.535

Data are expressed as mean SD or as number (percentage)

###### 

Operative data.

                                    Overall (n=755)   Women (n=197)   Men (n=558)   P Value
  --------------------------------- ----------------- --------------- ------------- -----------
  Valve type implanted                                                              
   Mechanical valve                 236 (31.3%)       57 (28.9%)      179 (32.1%)   0.413
   Stented xenogenic valve          387 (51.3%)       103 (52.3%)     284 (50.9%)   0.738
   Stentless xenogenic valve        100 (13.2%)       26 (13.2%)      74 (13.3%)    0.982
   Allograft                        20 (2.6%)         5 (2.5%)        15 (2.7%)     0.910
  Mitral valve surgery due to AIE   251 (33.2%)       75 (38.1%)      176 (31.5%)   0.094
  Mitral valve replacement          116 (15.4%)       39 (19.8%)      77 (13.8%)    **0.045**
  Mitral valve repair               49 (6.5%)         14 (7.1%)       35 (6.3%)     0.683
  Concomitant procedures                                                            
   TK                               55 (7.3%)         24 (12.2%)      31 (5.6%)     **0.002**
   Aorta ascendens                  233 (30.9%)       53 (26.9%)      180 (32.3%)   0.162
   Ablation                         22 (2.9%)         6 (3.0%)        16 (2.9%)     0.898
   CABG                             131 (17.4%)       32 (16.2%)      119 (17.8%)   0.633

###### 

Postoperative complications.

                                          Overall (n=755)   Women (n=197)   Men (n=558)   P Value
  --------------------------------------- ----------------- --------------- ------------- -----------
  Neurological complications (TIA, CVA)   194 (25.7%)       50 (25.4%)      144 (25.8%)   0.906
  Dialysis (postoperative)                153 (20.3%)       50 (25.4%)      103 (18.5%)   **0.038**
  Respiratory insufficiency               93 (12.3%)        21 (10.7%)      72 (12.9%)    0.410
  Tracheotomy                             78 (10.3%)        22 (11.2%)      56 (10.0%)    0.654
  PM implantation                         99 (13.1%)        24 (12.2%)      75 (13.4%)    0.766
  acute abdominal complications           42 (5.6%)         16 (8.1%)       26 (4.7%)     0.068
  Rethoracotomy                           97 (12.8%)        22 (11.2%)      75 (13.4%)    0.412

###### 

Cause of death.

                       Overall (n=755)   Women (n=197)   Men (n=558)   P Value
  -------------------- ----------------- --------------- ------------- -----------
  Causes of death                                                      
   Cerebral            26 (3.4%)         9 (4.6%)        17 (3.0%)     0.314
   Gastro-Intestinal   30 (4.0%)         7 (3.6%)        23 (4.1%)     0.725
   Bleeding            9 (1.2%)          4 (2.0%)        5 (0.9%)      0.207
   Cardiac             86 (11.4%)        22 (11.2%)      64 (11.5%)    0.909
   MOF/Sepsis          91 (12.1%)        34 (17.3%)      57 (10.2%)    **0.009**
   Pulmonary           30 (4.0%)         9 (4.6%)        21 (3.8%)     0.619
   Renal               7 (0.9%)          4 (2.0%)        3 (0.5%)      0.060
   Others              7 (0.9%)          3 (1.5%)        4 (0.7%)      0.310
   Tumor               29 (3.8%)         11 (5.6%)       18 (3.2%)     0.139
   Unknown             32 (4.2%)         5 (2.5%)        27 (4.8%)     0.168
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